Actively Recruiting
Endometrioma Sclerotherapy and Ovarian Preservation
Led by Chelsea and Westminster NHS Foundation Trust · Updated on 2025-11-25
60
Participants Needed
1
Research Sites
149 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A randomised controlled trial assessing ovarian reserve after laparoscopic ethanol sclerotherapy of ovarian endometrioma compared to standard treatment of surgical excision of endometrioma. Secondary outcomes will include endometrioma recurrence, symptomatology and inflammatory environment.
CONDITIONS
Official Title
Endometrioma Sclerotherapy and Ovarian Preservation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female (XX genotype, assigned female at birth)
- Age 18-40
- Suspected unilateral or bilateral ovarian endometrioma of 2 cm or larger on ultrasound or MRI
- Suitable for laparoscopic excision of endometrioma due to cyst size, pain, or to assist assisted reproductive technology
You will not qualify if you...
- Postmenopausal status
- Suspicion of malignancy
- Unable to undergo transvaginal ultrasound
- Declines participation
- Unable to understand English information
- Lacks capacity to consent at recruitment
- Known safeguarding issues
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chelsea and Westminster NHS Foundation Trust
London, United Kingdom, SW10 9NH
Actively Recruiting
Research Team
S
Sarah Bennet, BSc MBBS MRCOG
CONTACT
T
Thomas Bainton, BM BCh MRCOG MA(Oxon)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here